Pharma Rules/ Regulation
Harvard Medical School Revises Conflicts Policy
The Harvard Medical School’s Faculty of Medicine Committee on Conflicts of Interest issued a report last month on its review of the school’s 20-year-old COI policy. ...
ACCME Board Approves Complaint Process Revision
The Accreditation Council for Continuing Medical Education’s Board of Directors voted at its July meeting to approve a revised process for handling complaints regarding ACCME-accredited providers....
Healthcare Reform, Public Perception Mean Greater Scrutiny of Pharma Meetings
The uncertain future of the country's healthcare system has direct implications for biopharmaceutical and medical device companies, and in turn will affect the way these companies approach medical meetings and education, said Kim Slocum during a keynote address at the Sixth Annual Pharmaceutical Meeting Management Forum ...
Countering the AIG Effect
The AIG effect has hit the pharmaceutical meetings sector. During a closed-door summit for senior-level corporate planners at the Pharmaceutical Meeting...
Rx for Third Parties
With the pharmaceutical industry in flux, the economy in turmoil, and regulations on the rise, third-party meeting managers anticipate tough times ahead....
Dealing with the Downturn
Effective negotiating and cost-cutting strategies for meetings in a down economy...
CEJA Won't Seek Pharma Funding Ban for CME
The American Medical Association's Council on Ethical and Judicial Affairs won't recommend a ban on commercial support....
New Models, New Meetings
In the past six months, we have seen one or two challenges in our industry, joked Terri Breining, CMP, CMM, CEO and president of Concepts Worldwide Inc.,...
Ruling Out Resorts
The new PhRMA code says resorts are not appropriate meeting venues. But the definition of resort is open to debate....
A new law in Washington that requires pharmaceutical sales representatives to obtain a special license to sell pharmaceutical products in the District will not affect representatives attending medical meetings or conventions in D.C
A new law in Washington that requires pharmaceutical sales representatives to obtain a special license to sell pharmaceutical products in the District will not affect representatives attending medical meetings or conventions in D.C...
